Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Amarin (NASDAQ:AMRN) Stock Rating Lowered by StockNews.com
Amarin (NASDAQ:AMRN – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell”...
Workday (NASDAQ:WDAY) Lowered to “Hold” Rating by StockNews.com
Workday (NASDAQ:WDAY – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a...
Atlanticus (NASDAQ:ATLC) Price Target Raised to $75.00 at JMP Securities
Atlanticus (NASDAQ:ATLC – Free Report) had its target price lifted by JMP Securities from $54.00 to $75.00 in a research...
Guggenheim Reiterates Buy Rating for Benitec Biopharma (NASDAQ:BNTC)
Guggenheim reissued their buy rating on shares of Benitec Biopharma (NASDAQ:BNTC – Free Report) in a research note published on...
StockNews.com Begins Coverage on Express (NYSE:EXPR)
Equities research analysts at StockNews.com began coverage on shares of Express (NYSE:EXPR – Get Free Report) in a research report...
StockNews.com Begins Coverage on ClearSign Technologies (NASDAQ:CLIR)
StockNews.com assumed coverage on shares of ClearSign Technologies (NASDAQ:CLIR – Get Free Report) in a report released on Wednesday. The...